Statera Biopharma Inc (STAB)

$0.00 0.00 (N/A)
Market Cap 5,000.00
Revenue (ttm) 1.49M
Net Income (ttm) -101.85M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -6,835.57%
Debt to Equity Ratio 0.00
Volume 1,100
Avg Vol 8,532
Day's Range N/A - N/A
Shares Out 53.30M
Stochastic %K 50%
Beta 0.06
Analysts Strong Buy
Price Target N/A

Company Profile

Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. The company is developing therapies designed to directly elicit within patients a response of antigen-specific killer T-cells and antibodies, thereby activating essential immune defenses against autoimmune, inflammatory, inf...

Industry: Biotechnology
Sector: Healthcare
Phone: 888 613 8802
Address:
2580 East Harmony Road,, Suite 316, Fort Collins, United States
swishnetster
swishnetster Aug. 18 at 3:02 PM
$STAB Wake me up at $10 per share. Dreaming. Nevermind.
2 · Reply
swishnetster
swishnetster Aug. 13 at 4:06 PM
$STAB Hopien Hopian however you spell it I would mainline it .
0 · Reply
nu2thezu
nu2thezu Jul. 28 at 1:34 PM
$STAB https://news.biobuzz.io/2025/07/16/coeptis-therapeutics-announces-intent-to-acquire-tlr5-agonist-platform-including-clinical-stage-asset-entolimod-from-statera-biopharma/
1 · Reply
swishnetster
swishnetster Jul. 22 at 5:56 PM
$STAB 100,000 at .0001 is $10. ? Who chipped in?
0 · Reply
swishnetster
swishnetster May. 1 at 2:31 PM
$STAB Any thoughts on TIVC and a BUY at $4.38 10:30am may 1.
1 · Reply
swishnetster
swishnetster Apr. 28 at 2:23 PM
$STAB I attempted to average down and my account required me to call somebody. Never did so my question is. Can I buy this now? Should I average down? Will this ever trade? Seems like a great gamble. Oh, the call somebody may have meant a "shrink" lol
1 · Reply
scottcod
scottcod Apr. 22 at 1:32 PM
$STAB https://www.businesswire.com/news/home/20250422218401/en/Tivic-Health-Reports-White-House-Briefing-and-FDA-Meetings-Secured-Positive-Interest-in-Potential-Military-and-Defense-Applications-of-Its-Product-Candidates
1 · Reply
Unfazed22
Unfazed22 Apr. 8 at 8:30 PM
I'm starting to wish $STAB and $TIVC would merge. https://www.investing.com/news/sec-filings/tivic-health-expands-license-with-statera-biopharma-93CH-3966651
0 · Reply
Unfazed22
Unfazed22 Apr. 7 at 4:18 PM
$STAB I bought this during the pandemic at $52.03 and it looks like I'm gonna get fucked big time. Definitely a "no" vote for me.
2 · Reply
NVDAMillionaire
NVDAMillionaire Mar. 26 at 6:41 PM
$STAB Immunotherapy play with potential. AIMS platform looks promising. Watching STAT-201 Crohn's trial closely. Might take small position if financials stabilize. superb article: https://beyondspx.com/article/statera-biopharma-stab-building-an-innovative-immunotherapy-pipeline-to-address-unmet-medical-needs
0 · Reply
Latest News on STAB
No data available.
swishnetster
swishnetster Aug. 18 at 3:02 PM
$STAB Wake me up at $10 per share. Dreaming. Nevermind.
2 · Reply
swishnetster
swishnetster Aug. 13 at 4:06 PM
$STAB Hopien Hopian however you spell it I would mainline it .
0 · Reply
nu2thezu
nu2thezu Jul. 28 at 1:34 PM
$STAB https://news.biobuzz.io/2025/07/16/coeptis-therapeutics-announces-intent-to-acquire-tlr5-agonist-platform-including-clinical-stage-asset-entolimod-from-statera-biopharma/
1 · Reply
swishnetster
swishnetster Jul. 22 at 5:56 PM
$STAB 100,000 at .0001 is $10. ? Who chipped in?
0 · Reply
swishnetster
swishnetster May. 1 at 2:31 PM
$STAB Any thoughts on TIVC and a BUY at $4.38 10:30am may 1.
1 · Reply
swishnetster
swishnetster Apr. 28 at 2:23 PM
$STAB I attempted to average down and my account required me to call somebody. Never did so my question is. Can I buy this now? Should I average down? Will this ever trade? Seems like a great gamble. Oh, the call somebody may have meant a "shrink" lol
1 · Reply
scottcod
scottcod Apr. 22 at 1:32 PM
$STAB https://www.businesswire.com/news/home/20250422218401/en/Tivic-Health-Reports-White-House-Briefing-and-FDA-Meetings-Secured-Positive-Interest-in-Potential-Military-and-Defense-Applications-of-Its-Product-Candidates
1 · Reply
Unfazed22
Unfazed22 Apr. 8 at 8:30 PM
I'm starting to wish $STAB and $TIVC would merge. https://www.investing.com/news/sec-filings/tivic-health-expands-license-with-statera-biopharma-93CH-3966651
0 · Reply
Unfazed22
Unfazed22 Apr. 7 at 4:18 PM
$STAB I bought this during the pandemic at $52.03 and it looks like I'm gonna get fucked big time. Definitely a "no" vote for me.
2 · Reply
NVDAMillionaire
NVDAMillionaire Mar. 26 at 6:41 PM
$STAB Immunotherapy play with potential. AIMS platform looks promising. Watching STAT-201 Crohn's trial closely. Might take small position if financials stabilize. superb article: https://beyondspx.com/article/statera-biopharma-stab-building-an-innovative-immunotherapy-pipeline-to-address-unmet-medical-needs
0 · Reply
Lowlow1
Lowlow1 Mar. 26 at 4:47 PM
$STAB AGMH looking good for $1 run we.need to get there. 7 cents now low is 0.065 👀 🚀 ,.,.
0 · Reply
swishnetster
swishnetster Feb. 26 at 8:59 PM
$STAB Michael H, could you give us (shareholders) any kind of update? Good for you on job but what about us?
1 · Reply
scottcod
scottcod Feb. 25 at 9:57 PM
$STAB https://www.stocktitan.net/news/TIVC/tivic-health-names-biotech-industry-veteran-michael-k-handley-to-plqic59spbc4.html
1 · Reply
scottcod
scottcod Feb. 14 at 4:07 AM
$STAB https://www.businesswire.com/news/home/20250212860402/en/Tivic-Health-Acquires-Exclusive-Worldwide-Rights-to-Phase-III-TLR5-Agonist-from-Statera-Biopharma
1 · Reply
Unfazed22
Unfazed22 Feb. 11 at 5:24 AM
$STAB Web site is back up after about a week (last time it was down for a month or so if I remember right). Apparently, this company is trying to stay alive although the obstacles must be daunting - especially with interest rates so high. It likely needs a large cash infusion...but from where? Neither bullish nor bearish - just numb from it. Could be a years-long wait to see what happens - good or bad. It seems like a coin toss at this point.
1 · Reply
Unfazed22
Unfazed22 Feb. 4 at 5:00 PM
$STAB Still trading on OTC but web site is suspended again.
1 · Reply
scottcod
scottcod Feb. 4 at 12:43 AM
$STAB Wonder if this trial is for Stat-201? Dated Oct 1, 2024. Phase 3. https://www.crohnscolitisfoundation.org/a-phase-3-multi-center-study-to-evaluate-the-pharmacokinetics-efficacy-and-safety-of
2 · Reply
NVDAMillionaire
NVDAMillionaire Jan. 28 at 12:47 AM
$STAB Statera Biopharma, Inc. (NASDAQ:STAB): A Promising Immunotherapy Pipeline Hampered by Financial Challenges https://beyondspx.com/article/statera-biopharma-inc-stab-delivering-groundbreaking-immunotherapies-to-transform-patient-outcomes
0 · Reply
scottcod
scottcod Jan. 17 at 7:52 AM
$STAB
1 · Reply
scottcod
scottcod Dec. 18 at 11:02 PM
$STAB Statera is a leader in mRNA tech. Probably nothing, but… https://m.economictimes.com/news/international/global-trends/coming-soon-a-cancer-vaccine-for-free-courtsey-russia/amp_articleshow/116433827.cms
0 · Reply
NVDAMillionaire
NVDAMillionaire Dec. 5 at 3:24 AM
$STAB Statera Biopharma, Inc. (STAB): Delivering Groundbreaking Immunotherapies to Transform Patient Outcomes https://beyondspx.com/article/statera-biopharma-inc-stab-delivering-groundbreaking-immunotherapies-to-transform-patient-outcomes
0 · Reply
Unfazed22
Unfazed22 Oct. 18 at 4:51 AM
$STAB Letters of intent expire. Has anyone read the LOI with Worksite, which was signed 19 months ago? That's a really long time - has it been renegotiated? Honestly, I've never really been able to see the symbiosis between the two companies. Anyway, this stock isn't going anywhere until there's an uplisting on the OTC (for starters) because little trades between "expert investors" aren't going make this take off. One day I'll wake up and have a shit-ton of money or one day I'll wake up and this company will have disappeared. Who the hell knows? I'm hoping for the former.
1 · Reply